Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long Cao

Showing results (471-480 of 517) with videos related to

Pageof 52
Sort By:
Theranostics|February 24, 2022
The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancerQi-Yue Chen, Xiao-Bo Huang, Ya-Jun Zhao, et al.
Frontiers in Oncology|September 13, 2021
Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?Jiao-Bao Huang, Jun Lu, Dong Wu, et al.
Surgical Endoscopy|May 28, 2026
Post-surgical lymph node status guides perioperative chemotherapy completion for locally advanced gastric cancerYing-Xin Wu, Ze-Ning Huang, Yi-Fan Li, et al.
Nature Communications|December 14, 2020
An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancerJia-Bin Wang, Ping Li, Xiao-Long Liu, et al.
BMC Cancer|October 16, 2020
Effect of sarcopenia on short- and long-term outcomes in patients with gastric neuroendocrine neoplasms after radical gastrectomy: results from a large, two-institution seriesJia-Bin Wang, Zhen Xue, Jun Lu, et al.
JAMA Network Open|September 17, 2021
Characteristics and Research Waste Among Randomized Clinical Trials in Gastric CancerJun Lu, Bin-Bin Xu, Li-Li Shen, et al.
World Journal of Surgery|April 17, 2023
A Novel ypTLM Staging System Based on LODDS for Gastric Cancer After Neoadjuvant Therapy: Multicenter and Large-Sample Retrospective StudySi-Jin Que, Qing Zhong, Qi-Yue Chen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 23, 2023
The GLIM criteria as an effective tool for survival prediction in gastric cancer patientsHua-Long Zheng, Jia Lin, Li-Li Shen, et al.
NPJ Precision Oncology|October 28, 2025
Intratumoral plasma cells predict patient prognosis and responsiveness to neoadjuvant immunotherapy in advanced gastric cancerJia-Bin Wang, Chen-Yang Jiang, Yin-Hua Ye, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 21, 2022
Development and validation of metabolic scoring to individually predict prognosis and monitor recurrence early in gastric cancer: A large-sample analysisQi-Yue Chen, Si-Jin Que, Jun-Yu Chen, et al.
Pageof 52

Showing results (471-480 of 517) with videos related to

Sort By:
Pageof 52
Theranostics|February 24, 2022
The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancerQi-Yue Chen, Xiao-Bo Huang, Ya-Jun Zhao, et al.
Frontiers in Oncology|September 13, 2021
Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?Jiao-Bao Huang, Jun Lu, Dong Wu, et al.
Surgical Endoscopy|May 28, 2026
Post-surgical lymph node status guides perioperative chemotherapy completion for locally advanced gastric cancerYing-Xin Wu, Ze-Ning Huang, Yi-Fan Li, et al.
Nature Communications|December 14, 2020
An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancerJia-Bin Wang, Ping Li, Xiao-Long Liu, et al.
BMC Cancer|October 16, 2020
Effect of sarcopenia on short- and long-term outcomes in patients with gastric neuroendocrine neoplasms after radical gastrectomy: results from a large, two-institution seriesJia-Bin Wang, Zhen Xue, Jun Lu, et al.
JAMA Network Open|September 17, 2021
Characteristics and Research Waste Among Randomized Clinical Trials in Gastric CancerJun Lu, Bin-Bin Xu, Li-Li Shen, et al.
World Journal of Surgery|April 17, 2023
A Novel ypTLM Staging System Based on LODDS for Gastric Cancer After Neoadjuvant Therapy: Multicenter and Large-Sample Retrospective StudySi-Jin Que, Qing Zhong, Qi-Yue Chen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 23, 2023
The GLIM criteria as an effective tool for survival prediction in gastric cancer patientsHua-Long Zheng, Jia Lin, Li-Li Shen, et al.
NPJ Precision Oncology|October 28, 2025
Intratumoral plasma cells predict patient prognosis and responsiveness to neoadjuvant immunotherapy in advanced gastric cancerJia-Bin Wang, Chen-Yang Jiang, Yin-Hua Ye, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 21, 2022
Development and validation of metabolic scoring to individually predict prognosis and monitor recurrence early in gastric cancer: A large-sample analysisQi-Yue Chen, Si-Jin Que, Jun-Yu Chen, et al.
Pageof 52